Search
for
Sort by
Research 241–270 of 1000+
- Congenital adrenal hyperplasia
- Extensive alopecia areata: Not necessarily recalcitrant to therapy!
- The Application of Radiochemical Techniques to the Study of the Interaction of Hair Fibers with Aqueous Solutions
- Serum level of vitamin D in patients with alopecia areata
- Rethinking the classification of alopecia areata
- Addisonian crisis in a young man with atypical anorexia nervosa
- Janus Kinase Inhibitors for Alopecia Areata
- Successful treatment of resistant alopecia areata with a phototoxic dose of ultraviolet A after topical 8‐methoxypsoralen application
- Response of alopecia areata of the beard to oral tofacitinib
- Comparative Efficacy and Safety of Janus Kinase Inhibitors Used in Alopecia Areata: A Systematic Review and Meta-analysis
- Comparison of efficacy, safety and satisfaction of latanoprost versus minoxidil, betamethasone and in combination in patients with alopecia areata: A blinded multiple group randomized controlled trial
- Dupilumab for the treatment of alopecia areata in pediatric patients with atopic dermatitis: A scoping review
- Using artificial intelligence to compute Severity of Alopecia Tool scores
- European expert consensus statement on the systemic treatment of alopecia areata
- FDA approves Pfizer's JAK inhibitor for adolescents with alopecia areata hair loss
- 67 Patterns of clinical response in patients with alopecia areata (AA) treated with ritlecitinib in the ALLEGRO phase 2b/3 and ongoing, phase 3, ALLEGRO-LT studies
- Scalp hair regrowth is associated with improvements in health-related quality of life and psychological symptoms in patients with severe alopecia areata: results from two randomized controlled trials
- 34007 Efficacy and safety of baricitinib in adult patients with severe alopecia areata with or without an atopic background from 2 randomized, placebo-controlled, phase 3 trials
- New Instrumentation for Hair Transplantation Surgery
- Switching JAK inhibitors: evaluating baricitinib’s effectiveness in alopecia areata after tofacitinib failure
- Determination of serum 25-hydroxyvitamin D levels in patients with alopecia areata and their comparison with levels in healthy controls: A cross-sectional study
- Etiopathogenesis of Alopecia Areata
- Reply to: “Serum vitamin D level and disease severity of alopecia areata: A meta-regression analysis”
- Alopecia Areata in Skin of Color: Trichoscopic Analysis in Black/African American Patients
- Strong efficacy of ritlecitinib 50 mg and baricitinib 4 mg in alopecia areata, but further research needed to establish superiority
- 33774 Baricitinib results in eyebrow and eyelash growth in patients with alopecia areata who do not achieve 20% or less scalp hair loss
- 26143 Time to scalp hair, eyebrow, and eyelash improvement in patients with alopecia areata treated with baricitinib in the phase 2 portion of the phase 2/3 BRAVE-AA1 study
- Evaluation of vitamin D in pediatric alopecia areata: A case–control study of thirty patients in a tertiary care hospital
- Alopecia Areata
- Oral Baricitinib Restores Hair Loss in Alopecia Areata